Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6389 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
81-41 Atozet Merck Sharp & Dohme/Organon Healthcare GmbH Original drug not imported to China Approved in EU The 81st Batch of Reference Listed Drugs
81-42 Perdipine LTL Pharma Co.,Ltd Original drug not imported to China Approved in Japan The 81st Batch of Reference Listed Drugs
81-43 VEGAMOX Novartis Japan K.K. (ノバルティスファーマ株式会社) Original drug not imported to China Approved in Japan The 81st Batch of Reference Listed Drugs
81-44 Tarlige Daiichi Sankyo Co., Ltd. (第一三共株式会社) Original drug not imported to China Approved in Japan The 81st Batch of Reference Listed Drugs
80-1  则乐 Zai Lab (Shanghai) Co., Ltd. Original drug approved in China / The 80th Batch of Reference Listed Drugs
80-2  易来克 Kadmon Pharmaceuticals, LLC Original drug approved in China Original drug imported to China The 80th Batch of Reference Listed Drugs
80-3  Dilaudid Rhodes Pharmaceuticals LP Original drug not imported to China US Orange Book The 80th Batch of Reference Listed Drugs
80-4  Dilaudid Rhodes Pharmaceuticals LP Original drug not imported to China US Orange Book The 80th Batch of Reference Listed Drugs
80-5  Dilaudid Rhodes Pharmaceuticals LP Original drug not imported to China US Orange Book The 80th Batch of Reference Listed Drugs
80-6  Glucagon FRESENIUS KABI USA LLC Original drug not imported to China US Orange Book The 80th Batch of Reference Listed Drugs